Skip to main content
SpringerLink
Log in

Still sour about lactic acidosis years later: role of metformin in heart failure

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

Metformin remains a widely-used, first-line pharmacotherapy agent for patients with type 2 diabetes mellitus because of its efficacy, mild side effects, and affordability.

However, use of this medication has traditionally been shunned by clinicians in patient populations that are considered at risk of lactic acidosis, such as those with heart failure. The underutilization of metformin can largely be attributed to the historical stigma of its biguanide predecessor, phenformin, and its association with lactic acidosis. Despite various studies finding low rates of lactic acidosis and the United States Federal Drug Administration’s subsequent removal of heart failure from metformin’s contraindication labeling in 2006, this oral hypoglycemic remains underutilized in this patient population. In addition to reports of the safe use of metformin in the heart failure population, a multitude of studies have also additionally suggested a modest reduction in mortality and morbidity. Metformin’s role should be strongly reconsidered in the armamentarium of diabetes management in heart failure patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB (2004) The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care 27(8):1879–1884. https://doi.org/10.2337/diacare.27.8.1879

    Article  PubMed  Google Scholar 

  2. Nasir S, Aguilar D (2012) Congestive heart failure and diabetes mellitus: balancing glycemic control with heart failure improvement. Am J Cardiol 110(9 Suppl):50B–57B. https://doi.org/10.1016/j.amjcard.2012.08.031

    Article  PubMed  PubMed Central  Google Scholar 

  3. Targher G, Dauriz M, Laroche C, Temporelli PL, Hassanein M, Seferovic PM, Drozdz J, Ferrari R, Anker S, Coats A, Filippatos G, Crespo-Leiro MG, Mebazaa A, Piepoli MF, Maggioni AP, Tavazzi L, investigators E-HHL-TR (2017) In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA heart failure long-term registry. Eur J Heart Fail 19 (1):54–65. doi:https://doi.org/10.1002/ejhf.679

  4. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Jr., Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL, American College of Cardiology Foundation/American Heart Association Task Force on Practice G (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 128 (16):e240–e327. doi:https://doi.org/10.1161/CIR.0b013e31829e8776

  5. Kristensen SL, Preiss D, Jhund PS, Squire I, Cardoso JS, Merkely B, Martinez F, Starling RC, Desai AS, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, McMurray JJ, Packer M, Investigators P-H, Committees (2016) Risk related to pre-diabetes mellitus and diabetes mellitus in heart failure with reduced ejection fraction: insights from prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial. Circ Heart Fail 9 (1). doi:https://doi.org/10.1161/CIRCHEARTFAILURE.115.002560

  6. Chamberlain JJ, Herman WH, Leal S, Rhinehart AS, Shubrook JH, Skolnik N, Kalyani RR (2017) Pharmacologic therapy for type 2 diabetes: synopsis of the 2017 American Diabetes Association Standards of Medical Care in Diabetes. Ann Intern Med 166(8):572–578. https://doi.org/10.7326/M16-2937

    Article  PubMed  Google Scholar 

  7. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE (2017) Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm—2017 executive summary. Endocr Pract 23(2):207–238. https://doi.org/10.4158/EP161682.CS

    Article  PubMed  Google Scholar 

  8. DeFronzo R, Fleming GA, Chen K, Bicsak TA (2016) Metformin-associated lactic acidosis: current perspectives on causes and risk. Metabolism 65(2):20–29. https://doi.org/10.1016/j.metabol.2015.10.014

    Article  CAS  PubMed  Google Scholar 

  9. Glucophage® [prescribing information] (2017) Princeton, NJ: Bristol-Myers Squibb Company

  10. Bailey CJ, Turner RC (1996) Metformin. N Engl J Med 334(9):574–579. https://doi.org/10.1056/NEJM199602293340906

    Article  CAS  PubMed  Google Scholar 

  11. Swift TMM (2009) Metformin use in patients with diabetes and heart failure: cause for concern? Diabetes Spectrum 22(1):18–20. https://doi.org/10.2337/diaspect.22.1.18

    Article  Google Scholar 

  12. Center for Drug Evaluation and Research (1996) Supplemental new drug application approval for Glucophage®. Federal Drug Administration https://wwwaccessdatafdagov/drugsatfda_docs/nda/97/020357a_s006pdf Accessed 3 May 2017

  13. Kwong SC, Brubacher J (1998) Phenformin and lactic acidosis: a case report and review. J Emerg Med 16(6):881–886

    Article  CAS  PubMed  Google Scholar 

  14. Dembo AJ, Marliss EB, Halperin ML (1975) Insulin therapy in phenformin-associated lactic acidosis; a case report, biochemical considerations and review of the literature. Diabetes 24(1):28–35

    Article  CAS  PubMed  Google Scholar 

  15. Salpeter SR, Greyber E, Pasternak GA, Salpeter EE (2010) Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 4:CD002967. https://doi.org/10.1002/14651858.CD002967.pub4

    Google Scholar 

  16. Oates NS, Shah RR, Idle JR, Smith RL (1983) Influence of oxidation polymorphism on phenformin kinetics and dynamics. Clin Pharmacol Ther 34(6):827–834

    Article  CAS  PubMed  Google Scholar 

  17. Alkalay D, Khemani L, Wagner WE, Bartlett MF (1975) Pharmacokinetics of phenformin in man. J Clin Pharmacol 15(5–6):446–448

    Article  CAS  PubMed  Google Scholar 

  18. Andersson C, Olesen JB, Hansen PR, Weeke P, Norgaard ML, Jorgensen CH, Lange T, Abildstrom SZ, Schramm TK, Vaag A, Kober L, Torp-Pedersen C, Gislason GH (2010) Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study. Diabetologia 53(12):2546–2553. https://doi.org/10.1007/s00125-010-1906-6

    Article  CAS  PubMed  Google Scholar 

  19. Romero SP, Andrey JL, Garcia-Egido A, Escobar MA, Perez V, Corzo R, Garcia-Domiguez GJ, Gomez F (2013) Metformin therapy and prognosis of patients with heart failure and new-onset diabetes mellitus. A propensity-matched study in the community. Int J Cardiol 166(2):404–412. https://doi.org/10.1016/j.ijcard.2011.10.141

    Article  PubMed  Google Scholar 

  20. Lalau JD, Race JM (1999) Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations. Drug Saf 20(4):377–384

    Article  CAS  PubMed  Google Scholar 

  21. Stades AM, Heikens JT, Erkelens DW, Holleman F, Hoekstra JB (2004) Metformin and lactic acidosis: cause or coincidence? A review of case reports. J Intern Med 255(2):179–187

    Article  CAS  PubMed  Google Scholar 

  22. MacDonald MR, Eurich DT, Majumdar SR, Lewsey JD, Bhagra S, Jhund PS, Petrie MC, McMurray JJ, Petrie JR, McAlister FA (2010) Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. general practice research database. Diabetes Care 33(6):1213–1218. https://doi.org/10.2337/dc09-2227

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Masoudi FA, Inzucchi SE, Wang Y, Havranek EP, Foody JM, Krumholz HM (2005) Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study. Circulation 111(5):583–590. https://doi.org/10.1161/01.CIR.0000154542.13412.B1

    Article  CAS  PubMed  Google Scholar 

  24. Aguilar D, Chan W, Bozkurt B, Ramasubbu K, Deswal A (2011) Metformin use and mortality in ambulatory patients with diabetes and heart failure. Circ Heart Fail 4(1):53–58. https://doi.org/10.1161/CIRCHEARTFAILURE.110.952556

    Article  CAS  PubMed  Google Scholar 

  25. Crowley MJ, Diamantidis CJ, McDuffie JR, Cameron B, Stanifer J, Mock CK, Kosinski A, Wang X, Tang S, Williams JW, Jr. (2016) Metformin use in patients with contraindications or precautions. VA ESP project #09-010

  26. Eurich DT, Weir DL, Majumdar SR, Tsuyuki RT, Johnson JA, Tjosvold L, Vanderloo SE, McAlister FA (2013) Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34,000 patients. Circ Heart Fail 6(3):395–402. https://doi.org/10.1161/CIRCHEARTFAILURE.112.000162

    Article  CAS  PubMed  Google Scholar 

  27. Roussel R, Travert F, Pasquet B, Wilson PW, Smith SC, Jr., Goto S, Ravaud P, Marre M, Porath A, Bhatt DL, Steg PG, Reduction of Atherothrombosis for Continued Health Registry I (2010) Metformin use and mortality among patients with diabetes and atherothrombosis. Arch Intern Med 170 (21):1892–1899. doi:https://doi.org/10.1001/archinternmed.2010.409

  28. Ekstrom N, Schioler L, Svensson AM, Eeg-Olofsson K, Miao Jonasson J, Zethelius B, Cederholm J, Eliasson B, Gudbjornsdottir S (2012) Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register. BMJ Open 2(4). https://doi.org/10.1136/bmjopen-2012-001076

  29. Roumie CL, Min JY, D'Agostino McGowan L, Presley C, Grijalva CG, Hackstadt AJ, Hung AM, Greevy RA, Elasy T, Griffin MR (2017) Comparative safety of sulfonylurea and metformin monotherapy on the risk of heart failure: a cohort study. J Am Heart Assoc 6(4). https://doi.org/10.1161/JAHA.116.005379

  30. Administration FD (2016) FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function: safety announcement https://www.fda.gov/downloads/drugs/drugsafety/ucm494140.pdf. Accessed 3 May 2017

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy Services, University of Kentucky Albert B. Chandler Hospital, 800 Rose Street, Room H110, Lexington, KY, 40536, USA

    William Kuan & Craig J. Beavers

  2. Division of Cardiovascular Medicine, Gill Heart & Vascular Institute, University of Kentucky Albert B. Chandler Hospital, 800 Rose Street, Lexington, KY, 40536, USA

    Maya E. Guglin

Authors
  1. William Kuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Craig J. Beavers
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maya E. Guglin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William Kuan.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kuan, W., Beavers, C.J. & Guglin, M.E. Still sour about lactic acidosis years later: role of metformin in heart failure. Heart Fail Rev 23, 347–353 (2018). https://doi.org/10.1007/s10741-017-9649-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10741-017-9649-9

Keywords

Search

Navigation